RecruitingSocial Anxiety Disorder (SAD)

Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

Eligible age

18–65 yrs

Accepts

All genders

Locations

16 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.

Sponsor: Vanda Pharmaceuticals

You may qualify if…

✓ 1. Ability and willingness to provide written informed consent.
✓ 2. Male and female subjects aged 18-65 years, inclusive.
✓ 3. Current diagnosis of social anxiety disorder.
✓ 4. Liebowitz Social Anxiety Scale total score ≥60.
✓ 5. Public Speaking Anxiety Scale total score ≥60.
✓ 6. Hamilton Depression Rating Scale score ≤18.

You may not qualify if…

✕ 1. Suicide attempts and/or suicidal ideation in the past 2 years or currently at risk of suicide in the opinion of the investigator.
✕ 2. History of bipolar disorder, schizophrenia, psychosis, seizures, delusional disorders, obsessive-compulsive disorder, or autism spectrum disorder.
✕ 3. Posttraumatic stress disorder or an eating disorder in the past 6 months.
✕ 4. Substance or alcohol use disorder in the past 6 months or positive in drug/alcohol screening.
✕ 5. Psychotherapy in the past 6 months.
✕ 6. Psychotropic medication in the past 2 months.
✕ 7. Current or planned pregnancy or nursing during the trial period.
✕ 8. Any other reason as determined by the Investigator which may lead to an unfavorable risk-benefit of study participation, or interference with study objectives.